Candida tropicalis-A systematic review to inform the World Health Organization of a fungal priority pathogens list.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 09 09 2023
revised: 14 01 2024
accepted: 29 04 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: ppublish

Résumé

In response to the growing global burden of fungal infections with uncertain impact, the World Health Organization (WHO) established an Expert Group to identify priority fungal pathogens and establish the WHO Fungal Priority Pathogens List for future research. This systematic review aimed to evaluate the features and global impact of invasive candidiasis caused by Candida tropicalis. PubMed and Web of Science were searched for studies reporting on criteria of mortality, morbidity (defined as hospitalization and disability), drug resistance, preventability, yearly incidence, diagnostics, treatability, and distribution/emergence from 2011 to 2021. Thirty studies, encompassing 436 patients from 25 countries were included in the analysis. All-cause mortality due to invasive C. tropicalis infections was 55%-60%. Resistance rates to fluconazole, itraconazole, voriconazole and posaconazole up to 40%-80% were observed but C. tropicalis isolates showed low resistance rates to the echinocandins (0%-1%), amphotericin B (0%), and flucytosine (0%-4%). Leukaemia (odds ratio (OR) = 4.77) and chronic lung disease (OR = 2.62) were identified as risk factors for invasive infections. Incidence rates highlight the geographic variability and provide valuable context for understanding the global burden of C. tropicalis infections. C. tropicalis candidiasis is associated with high mortality rates and high rates of resistance to triazoles. To address this emerging threat, concerted efforts are needed to develop novel antifungal agents and therapeutic approaches tailored to C. tropicalis infections. Global surveillance studies could better inform the annual incidence rates, distribution and trends and allow informed evaluation of the global impact of C. tropicalis infections.

Identifiants

pubmed: 38935905
pii: 7700345
doi: 10.1093/mmy/myae040
pii:
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education and Science
Organisme : World Health Organization
Pays : International

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Caitlin Keighley (C)

Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia.
Southern IML Pathology, 3 Bridge St, Coniston, NSW, Australia.

Hannah Yejin Kim (HY)

Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Westmead Hospital, Westmead, NSW, Australia.

Sarah Kidd (S)

National Mycology Reference Centre, Microbiology & Infectious Diseases, SA Pathology, Adelaide, SA, Australia.
School of Biological Sciences, University of Adelaide, Adelaide, SA, Australia.

Sharon C-A Chen (SC)

Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia.

Ana Alastruey (A)

Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

Aiken Dao (A)

Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
Westmead Hospital, Westmead, NSW, Australia.

Felix Bongomin (F)

Department of Medical Microbiology & Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda.

Tom Chiller (T)

Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GE, USA.

Retno Wahyuningsih (R)

Department of Parasitology, Faculty of Medicine, Universitas Kristen Indonesia, Jakarta, Indonesia.

Agustina Forastiero (A)

Servicio de Micologia, Laboratorio de Microbiologia, Hospital Britanico, Buenos Aires, Argentina.

Adi Al-Nuseirat (A)

World Health Organization Regional Office for the Eastern Mediterranean, Cairo 11371, Egypt.

Peter Beyer (P)

AMR Division, World Health Organization, Geneva.

Valeria Gigante (V)

AMR Division, World Health Organization, Geneva.

Justin Beardsley (J)

Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
Westmead Hospital, Westmead, NSW, Australia.

Hatim Sati (H)

AMR Division, World Health Organization, Geneva.

C Orla Morrissey (CO)

The Alfred Hospital, Department of Infectious Diseases, Melbourne, Victoria, Australia.
Monash University, Department of Infectious Diseases, Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Melbourne, Victoria, Australia.

Jan-Willem Alffenaar (JW)

Sydney Infectious Diseases Institute, The University of Sydney, Sydney, NSW, Australia.
Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia.
Westmead Hospital, Westmead, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH